Journal Article10.1038/13590
Defining epitopes: It's not as easy as it seems.
Neil S. Greenspan,Di Cera E +1 more
492
About: This article is published in Nature Biotechnology. The article was published on 01 Oct 1999.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
Robert Anthony Williamson,Jehangir Wadia,Gabriel Pascual,Elissa Keogh +3 more
- 08 Jul 2011
TL;DR: In this article, the authors provided methods for the prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease, and methods of generating antibodies that immunospecifically bind RSV F protein.
27
Patent
Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer
David V. Gold,David M. Goldenberg +1 more
- 13 Feb 2012
TL;DR: In this paper, compositions and methods of use of anti-pancreatic cancer antibodies or fragments thereof, such as murine, chimeric, humanized or human PAM4 antibodies show novel and useful diagnostic characteristics.
26
Patent
Anti-EGFR antibodies and antibody drug conjugates
Edward B. Reilly,Andrew C. Phillips,Lorenzo Benatuil,Fritz G. Buchanan,Jonathan A. Meulbroek,Hsieh Chung-Ming,Jennifer Perez +6 more
- 20 Mar 2015
TL;DR: In this paper, the authors described compositions and methods of using anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and method of using said antibodies and ADCs.
26
Patent
Method of promoting bone growth by an anti-actriia antibody
John Knopf,Jasbir Seehra +1 more
- 11 Jul 2013
26
Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibition.
TL;DR: The three dimensional localization of this epitope and its differential exposure in active and latent forms of PAI-1 provide a molecular explanation for the underlying mechanism of MA-33B8.
26
References
A hot spot of binding energy in a hormone-receptor interface
Tim Clackson,James A. Wells +1 more
TL;DR: The x-ray crystal structure of the complex between human growth hormone and the extracellular domian of its first bound receptor (hGHbp) shows that about 30 side chains from each protein make contact, which resembles a cross section through a globular protein.
2K
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.
TL;DR: The overall folding of these mutant proteins was indistinguishable from that of the wild-type hGH, as determined by strong cross-reactivities with seven different conformationally sensitive monoclonal antibodies.
1.9K
The interaction of thrombin with fibrinogen. A structural basis for its specificity.
Milton T. Stubbs,Hartmut Oschkinat,Irmgard Mayr,Robert Huber,Herbert Angliker,Stuart R. Stone,Wolfram Bode +6 more
TL;DR: The surface topology of the thrombin molecule indicates positions P1'-P3', differ from those of the canonical serine-proteinase inhibitors, suggesting a mechanical model for the switching ofThrombin activity from fibrinogen cleavage to protein-C activation on thrombomodulin complex formation.
222
From absolute to exquisite specificity. Reflections on the fuzzy nature of species, specificity and antigenic sites.
TL;DR: The term specificity is derived from the word species and shares with it an inherent fuzziness based on the absence of sharp boundaries between closely related entities and this poses no threat to the unabated further development of immunochemical analysis.
107
Rational engineering of activity and specificity in a serine protease
TL;DR: It is demonstrated that rational site-directed mutagenesis of residues controlling Na+ binding can profoundly alter the properties of a serine protease, and by suppressing Na+binding to thrombin, the balance between procoagulant and anticoagulants activities of the enzyme is shifted.
105